How does insulin-treated diabetes affect aviation medical certification in many jurisdictions?

• A. It has no impact on certification
• B. Often disqualifying or requiring special issuance and comprehensive medical oversight
• C. It enhances certification
• D. It is automatically disqualifying with no possibility of special issuance

Answer: (B)

Insulin-treated diabetes introduces a real safety concern for flying because of the risk of hypoglycemia and the need for reliable, ongoing glucose management. Aviation medical authorities treat this condition with caution, so a standard, unrestricted medical certificate is often not available. Instead, pilots using insulin typically face a path that requires a special issuance—the certificate is granted only under extra conditions and with ongoing medical oversight. This usually means demonstrating stable glycemic control, the ability to recognize and treat hypoglycemia in flight, and regular medical follow-up, sometimes with additional documentation or monitoring (for example, endocrinology input or glucose monitoring data). Because of these safety considerations, insulin-treated diabetes is not treated as having no impact and it is not automatically disqualifying without any remedy; there is commonly a route to certification only through a special issuance process with comprehensive oversight.